Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-22T17:31:48.233Z Has data issue: false hasContentIssue false
  • English
  • Français

Comparison of Long Term Results Between Prolactin Secreting Adenomas and ACTH Secreting Adenomas

Published online by Cambridge University Press:  18 September 2015

Kalmon D. Post  and
Jo-Ellen Habas
Kalmon D. Post*
Affiliation:
Department of Neurological Surgery, College of Physicians and Surgeons, Columbia University, New York
Jo-Ellen Habas
Affiliation:
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York
*
Professor and Vice Chairman, Department of Neurological Surgery, College of Physicians and Surgeons, Columbia University, New York, New York 10032 USA
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A series of 100 prolactin secreting pituitary adenomas was reviewed and demonstrated an early cure rate of 85.2% with a cure rate of 89% if prolactin was less than 200 ng/ml. For macroadenomas the cure rate was 50% giving an overall cure rate of 71% for the entire group. When long term (> 5 years) followup was obtained a 17% incidence of recurrence was noted for the microadenoma group with a 20% recurrence rate for the macroadenoma group. Secretory dynamic studies were done shortly after surgery and then after a delay. Many showed a return to normal prolactin secretory dynamics suggesting that the underlying hypothalamic regulation is normal in most patients. Abnormal secretory dynamics at 6 weeks post operative testing were not predictive of which patients would relapse as many patients who had abnormal dynamics early did not relapse even during prolonged followup. Conversely a normal response to provocative testing did not preclude late relapse. A similar series of 40 consecutive patients with Cushing's disease was reviewed. Tumor was found in all but three cases. 84% of patients were cured and thus far only one patient (2.5%) has shown late recurrence with this occurring at 62/3 years following surgery with normal stimulatory dynamics present for five years. The implication is that hypothalamic regulation is normal in Cushing's disease as well. The differences in recurrence rates may be reflective of the aggressiveness with which one disease is treated, with the acceptance of a higher incidence of hypopituitarism as a consequence of more radical surgery for Cushing's disease.

Type
Special Supplement - Secreting Pituitary Adenomas
Information
Canadian Journal of Neurological Sciences , Volume 17 , Issue 1 , February 1990 , pp. 74 - 77
Copyright
Copyright © Canadian Neurological Sciences Federation 1990

References

REFERENCES

1.Rodman, EF, Molitch, ME, Post, KD, et al. Long term follow-up of transsphenoidal selective adenomectomy of prolactinoma. JAMA 1984; 252: 921–924.CrossRefGoogle ScholarPubMed
2.Tucker, HSG, Grubb, SR, Wigand, JP, et al. Galactorrhea-amenorrheasyndrome: followup of 45 patients after pituitary tumor removal. Ann Intern Med 1982; 94: 302–307.CrossRefGoogle Scholar
3.Giovanelli, G, Gaini, SR, Tomei, G, et al. Follow-up review of microprolactinomas operated in 48 female patients. Excerpta Med Int Congr Ser 1982; 584: 189–196.Google Scholar
4.Camanni, F, Ghigo, E, Ciccarelli, E, et al. Follow-up of 69 patients after pituitary tumor removal for hyperprolactinemia. Excerpta Med Int Congr Ser 1982; 584: 205–213.Google Scholar
5.Nencioni, T, Miragoli, A, Bertaglia, MG, et al. Medical and surgical treatment of microprolactinomas: long term follow-up. Excerpta Med Int Congr Ser 1982; 584: 215–218.Google Scholar
6.Barharino, A, DeMarinis, L, Anile, C, et al. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactinsecreting pituitary adenomas: long term studies after selective transsphenoidal surgery. Metabolism 1982; 31: 1100–1104.Google Scholar
7.Oldfield, EH, Chrousos, GP, Schulte, HM, et al. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 1985; 312: 100–103.CrossRefGoogle ScholarPubMed
8.Landolt, AM, Valavanis, A, Girard, J, et al. Corticotrophin-releasing factor test used with bilateral, simultaneous inferior petrosal sinus blood-sampling for the diagnosis of pituitary-dependent Cushing’s disease. Clin Endocrinol 1986; 25: 687–696.CrossRefGoogle ScholarPubMed
9.Boggan, JE, Tyrrell, JB, Wilson, CB.Transsphenoidal microsurgical manangement of Cushing’s disease, report of 100 cases. J Neurosurg 1983; 59: 195–200.CrossRefGoogle Scholar
10.Thomas, JP, Richards, SH.Long term results of radical hypophysectomy for Cushing’s disease. Clin Endocrinol 1983; 19: 629–636.CrossRefGoogle ScholarPubMed
11.Nakane, T, Kuwayama, A, Watanabe, M, et al. Long term results of transsphenoidal adenomectomy in patients with Cushing’s disease. Neurosurgery 1987; 21: 218–222.Google ScholarPubMed
12.Hardy, J.Presidential address: XVII Canadian Congress of Neurological Sciences. Cushing’s disease: 50 years later. Can J Neurol Sci 1982; 375–380.CrossRefGoogle ScholarPubMed
13.Styne, DM, Grumbach, MM, Kaplan, SL, et al. Treatment of Cushing’s disease in childhood and adolescence by transsphenoidal microadenomectomy. N Engl J Med 1984; 310: 889–893.CrossRefGoogle ScholarPubMed
14.Serri, O, Rasio, E, Beauregard, H, et al. Recurrence of hyperprolactinoma after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med 1983; 309: 280–283.CrossRefGoogle Scholar
15.Fitzgerald, PA, Aron, DA, Findling, JW, et al. Cushing’s disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J Clin Endocrinol Metab 1982; 54: 413–422.CrossRefGoogle ScholarPubMed
16.Kasperlik-Zuluska, AA, Nielubowicz, J, Wislawski, J, et al. Nelson’s syndrome: incidence and prognosis. Clin Endocrinol 1983; 19: 693–698.CrossRefGoogle Scholar